Coronavirus updates: Herd immunity by fall 'ambitious,' says surgeon general nominee

Before the end of the month, London will begin piloting COVID-19 vaccination sites that will be open 24 hours a day, seven days a week, according to Nadhim Zahawi, the United Kingdom's minister for COVID-19 vaccine deployment.

England's National Health Service (NHS) will trial the round-the-clock vaccination sites at hospitals in the British capital.

"And we'll look at how we expand that," Zahawi told Sky News in an interview Monday.

Zahawi said the key with 24-hour vaccination sites is to ensure vulnerable populations, such as people over 80 and others deemed high-risk, are still being targeted.

"At the moment, the challenge is obviously supply -- limited supply vaccine that needs to get into the arms of the most vulnerable four cohorts. So the targeting has to be really, really precise so that we can protect them by mid-February," he added.

"So if you just want to chase volume, chase speed and not accuracy, 24 hours works really well," he continued. "If you want to chase both accuracy, protecting the most vulnerable and of course speed, then you want to do what we're doing which is primary care networks, hospitals, large vaccination centers and of course pharmacies."

As of Saturday, 3,857,266 people in the U.K. have received the first of two doses of a COVID-19 vaccine, according to the latest data published on the U.K. government's website.

The U.K. Medicines and Healthcare products Regulatory Agency (MHRA) has approved three COVID-19 vaccines for use to date -- one developed by U.S. pharmaceutical giant Pfizer and its German partner BioNTech, a second developed by England's University of Oxford and British-Swedish pharmaceutical company AstraZeneca, and a third developed by American biotechnology firm Moderna.

The U.K. -- an island nation of 66 million people made up of England, Scotland, Wales and Northern Ireland -- has confirmed more than 3.3 million cases of COVID-19 since the start of the pandemic, including over 89,000 deaths. There were 38,598 new cases and 671 additional deaths confirmed over the past 24 hours, according to the latest data.

People aged 75 and over will be eligible to receive a COVID-19 vaccine in France starting Monday.

Up until now, only residents of nursing homes and medical staff aged 50 and over were able to be vaccinated against the disease.

France is also expanding its vaccination campaign to include anyone with high-risk conditions, such as cancer patients undergoing chemotherapy or transplant patients.

The move comes after the country's death toll from COVID-19 topped 70,000 over the weekend.

France has confirmed more than 2.9 million cases of COVID-19 since the start of the pandemic, including at least 70,283 deaths, according to the latest data from the country's public health agency. The Western European nation has the sixth-highest tally of diagnosed cases in the world, after the United States, India, Brazil, Russia and the United Kingdom, according to a real-time count kept by Johns Hopkins University.

So far, the European Medicines Agency has approved two COVID-19 vaccines for use in the European Union -- one developed by U.S. pharmaceutical giant Pfizer and its German partner BioNTech, and another developed by American biotechnology company Moderna.

ABC News' Ibtissem Guenfoud contributed to this report.

A public school district in Oklahoma City canceled basketball games on Friday night after witnessing what it called a "super-spreader event."

Millwood Public Schools said it "made the decision to put kids and families first," pulling its basketball players off the court during games against Community Christian School in Norman, about 20 miles south of downtown Oklahoma City. The school district posted photos on Facebook showing a crowded gymnasium with few people wearing masks or maintaining distances.

"We will NOT subject our kids and families to a super-spreader event just to compete," Millwood Public Schools wrote in the Facebook post Friday night.

Community Christian School's athletics director, Mat McIntosh, told Oklahoma City ABC affiliate KOCO-TV that the photos shared on social media showed the home side, which "was three-fourths full." He said that they "would never put any students at risk."

"During [Friday] night’s game when the decision was made to pull the players off the court, we were caught off guard," McIntosh said in a statement. "We hated that. It has been our desire to keep things as normal as possible. We have policies in place for COVID during athletic events. As a school, we have listened to the governor’s statement to stay at 50% capacity. We feel even [Friday] night, our overall capacity was under 50%."

More than one million people have received the first of two doses of a COVID-19 vaccine in Germany, according to the country's public health agency.

As of Saturday, 1,048,160 first doses had been administered nationwide, according to the latest data from the Robert Koch Institute. So far, the European Medicines Agency has approved two COVID-19 vaccines for use in the European Union -- one developed by U.S. pharmaceutical giant Pfizer and its German partner BioNTech, and another developed by American biotechnology company Moderna.

There were 7,141 new cases of COVID-19 confirmed in Germany on Sunday. An additional 214 deaths from the disease were also registered nationwide. That brings the country's cumulative totals to 2,040,659 cases with 46,633 deaths, according to the Robert Koch Institute.